Advisors Management Group’s AbbVie ABBV Stock Holding History

Advisors Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$225K	Sell	1,035 -2	-0.2%	-$444	0.04%	149
2025 Q4	$237K	Sell	1,037 -9	-0.9%	-$2.05K	0.04%	147
2025 Q3	$242K	Buy	+1,046	New	+$213K	0.04%	143
2025 Q2	–	Sell	-1,059	Closed	-$222K	–	149
2025 Q1	$222K	Buy	+1,059	New	+$206K	0.05%	141
2024 Q4	–	Sell	-1,058	Closed	-$209K	–	151
2024 Q3	$209K	Buy	+1,058	New	+$197K	0.05%	145
2024 Q2	–	Sell	-1,242	Closed	-$226K	–	155
2024 Q1	$226K	Buy	+1,242	New	+$214K	0.06%	145
2023 Q1	–	Sell	-1,843	Closed	-$298K	–	142
2022 Q4	$298K	Buy	1,843 +12	+0.7%	+$1.84K	0.11%	101
2022 Q3	$246K	Buy	1,831 +188	+11%	+$27K	0.1%	109
2022 Q2	$252K	Buy	1,643 +49	+3%	+$7.49K	0.09%	111
2022 Q1	$258K	Buy	1,594 +3	+0.2%	+$436	0.09%	109
2021 Q4	$215K	Buy	+1,591	New	+$188K	0.06%	123

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisors Management Group's ABBV Position: Q1 2026 in Review

Advisors Management Group reduced its AbbVie (ABBV) stake by 0.19% in Q1 2026, selling an estimated $444 and leaving 1,035 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #149.

Advisors Management Group first reported a position in ABBV in Q4 2021 and has held it in 11 quarters since. The position peaked at $298K in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Advisors Management Group held 1,035 shares of AbbVie worth $225K as of Q1 2026.
Advisors Management Group sold 2 AbbVie shares in Q1 2026, an estimated $444.
AbbVie made up 0.04% of Advisors Management Group's portfolio in Q1 2026, its #149 holding.
Advisors Management Group first reported a position in AbbVie in Q4 2021 and has held it in 11 quarters since.
Advisors Management Group's AbbVie position peaked at $298K in Q4 2022.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.